While TRO significantly increased both caveolin-1 and PPARγ levels in SSc monocytes, it had an intermediate effect on AA monocytes, and little or no effect on caveolin-1 and PPARγ in C monocytes. This evidence concerns the gene PPARG and systemic sclerosis.